更正：肌肉减少症和肌肉减少性肥胖是可切除胰腺导管腺癌独立的不良预后因素。
Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
作者信息
Gruber Elisabeth S, Jomrich Gerd, Tamandl Dietmar, Gnant Michael, Schindl Martin, Sahora Klaus
出版信息
PLoS One. 2020 Dec 29;15(12):e0244896. doi: 10.1371/journal.pone.0244896. eCollection 2020.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0215915.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0215915。]
相似文献
1
Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
PLoS One. 2020 Dec 29;15(12):e0244896. doi: 10.1371/journal.pone.0244896. eCollection 2020.
2
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
PLoS One. 2019 May 6;14(5):e0215915. doi: 10.1371/journal.pone.0215915. eCollection 2019.
3
Correction: Bed-side measures for diagnosis of low muscle mass, sarcopenia, obesity, and sarcopenic obesity in patients with chronic kidney disease under non-dialysis-dependent, dialysis dependent and kidney transplant therapy.
PLoS One. 2021 Apr 8;16(4):e0250186. doi: 10.1371/journal.pone.0250186. eCollection 2021.
4
Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Pancreatology. 2015 Jan-Feb;15(1):19-24. doi: 10.1016/j.pan.2014.11.006. Epub 2014 Dec 4.
5
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Clin Nutr. 2016 Jun;35(3):724-30. doi: 10.1016/j.clnu.2015.05.011. Epub 2015 May 27.
6
Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Surg Today. 2016 May;46(5):583-92. doi: 10.1007/s00595-015-1206-3. Epub 2015 Jun 25.
7
Correction: Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells.
PLoS One. 2019 Jul 2;14(7):e0219419. doi: 10.1371/journal.pone.0219419. eCollection 2019.
8
Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity.
Obesity (Silver Spring). 2016 Feb;24(2):526-34. doi: 10.1002/oby.21356.
9
Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):199-206. doi: 10.1002/jcsm.12371. Epub 2019 Jan 21.
10
Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
PLoS One. 2018 Apr 19;13(4):e0196354. doi: 10.1371/journal.pone.0196354. eCollection 2018.
引用本文的文献
1
Sarcopenic obesity in cancer.
Radiol Oncol. 2024 Feb 21;58(1):1-8. doi: 10.2478/raon-2024-0011. eCollection 2024 Mar 1.
2
Oral Nutritional Supplements and Enteral Nutrition in Patients with Gastrointestinal Surgery.
Nutrients. 2021 Jul 30;13(8):2655. doi: 10.3390/nu13082655.
本文引用的文献
1
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
PLoS One. 2019 May 6;14(5):e0215915. doi: 10.1371/journal.pone.0215915. eCollection 2019.
Zotero 插件